Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155307 | SCV000204993 | benign | not specified | 2017-07-06 | criteria provided, single submitter | clinical testing | p.Ala1923Thr in exon 16 of TRIOBP: This variant is not expected to have clinica l significance because it has been identified in 0.8% (75/9030) of Ashkenazi Jew ish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadi nstitute.org; dbSNP rs150947392). In addition, it is not conserved across specie s, including mammals. Of note, bushbaby, mouse, rat, kangaroo rat, and sloth hav e a threonine (Thr) at this position despite high nearby amino acid conservation . |
Labcorp Genetics |
RCV001517721 | SCV001726283 | benign | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001517721 | SCV001756391 | likely benign | not provided | 2020-10-06 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29197352, 28089734, 26969326) |
Ce |
RCV001517721 | SCV004147868 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TRIOBP: BP4, BS2 |
Breakthrough Genomics, |
RCV001517721 | SCV005206438 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003937459 | SCV004747837 | benign | TRIOBP-related disorder | 2024-09-11 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |